Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dror, Sayar"'
Autor:
Nivin Moustafa-Hawash, Dror Sayar, Ronit Elhasid, Tali Tohami, Jonathan Ben-Ezra, Shai Izraeli
Publikováno v:
Journal of Pediatric Hematology/Oncology. 34:565-568
Spontaneous remission in 2 children with myelofibrosis, one with megakaryocytic acute myeloblastic leukemia and t(1;22) (with recurrence later) and one with Down syndrome and GATA1 mutation (permanent), are described. One had sepsis and was treated w
Publikováno v:
Pediatric Blood & Cancer.
Gemtuzumab ozogamicin (GO) is a humanized anti-CD33 antibody used for treating patients with CD33+ acute myeloid leukemia (AML). We report three young children (two infants and one toddler) with AML treated with GO 9 mg/m2. Two received two doses at
Publikováno v:
Harefuah. 148(1)
Toxocariasis is one of the causes of eosinophilia in peripheral blood and provokes eosinophilic infiltration in internal organs. In Israel, the number of cases of toxocariasis is very low, 3 cases annually, according to the records at the Ministry of
Autor:
Ur Metser, Isaac Yaniv, Amos Toren, Dalia Valdman, Yoav Burstein, Galia Avrahami, Elka Miller, Einat Even-Sapir, Rina Dvir, Dror Sayar, Liat Ben Sira
Publikováno v:
Journal of computer assisted tomography. 30(4)
Objective: To assess the role of 18 F-Fluorodeoxyglucose ( 18 F-FDG) PET/CT in pediatric patients with Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL). Materials and Methods: 31 patients, mean age 12.9 ± 5.1, HD (n = 24), and NHL (n = 7) underwe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dror, Sayar
Publikováno v:
Pediatric Blood & Cancer; Mar2013, Vol. 60 Issue 3, p506-507, 2p